nodes	percent_of_prediction	percent_of_DWPC	metapath
Zaleplon—Snoring—Varenicline—nicotine dependence	0.038	0.064	CcSEcCtD
Zaleplon—Somnambulism—Varenicline—nicotine dependence	0.0275	0.0462	CcSEcCtD
Zaleplon—Facial paralysis—Varenicline—nicotine dependence	0.0173	0.0292	CcSEcCtD
Zaleplon—GABRB2—GABA A receptor activation—GABRA4—nicotine dependence	0.0156	0.0385	CbGpPWpGaD
Zaleplon—Anger—Varenicline—nicotine dependence	0.0154	0.026	CcSEcCtD
Zaleplon—GABRA2—GABA A receptor activation—GABRA4—nicotine dependence	0.0146	0.0361	CbGpPWpGaD
Zaleplon—GABRB3—GABA A receptor activation—GABRA4—nicotine dependence	0.0145	0.0358	CbGpPWpGaD
Zaleplon—GABRG2—GABA A receptor activation—GABRA4—nicotine dependence	0.0143	0.0352	CbGpPWpGaD
Zaleplon—VIIth nerve paralysis—Varenicline—nicotine dependence	0.0134	0.0226	CcSEcCtD
Zaleplon—GABRA1—GABA A receptor activation—GABRA4—nicotine dependence	0.0125	0.0307	CbGpPWpGaD
Zaleplon—Aphthous stomatitis—Varenicline—nicotine dependence	0.0118	0.0198	CcSEcCtD
Zaleplon—Myositis—Varenicline—nicotine dependence	0.0112	0.0189	CcSEcCtD
Zaleplon—Hostility—Varenicline—nicotine dependence	0.00996	0.0168	CcSEcCtD
Zaleplon—Osteoporosis—Varenicline—nicotine dependence	0.00984	0.0166	CcSEcCtD
Zaleplon—GABRB2—Ligand-gated ion channel transport—GABRA4—nicotine dependence	0.00955	0.0236	CbGpPWpGaD
Zaleplon—Vaginal discharge—Varenicline—nicotine dependence	0.00906	0.0153	CcSEcCtD
Zaleplon—GABRA2—Ligand-gated ion channel transport—GABRA4—nicotine dependence	0.00896	0.0221	CbGpPWpGaD
Zaleplon—GABRB3—Ligand-gated ion channel transport—GABRA4—nicotine dependence	0.0089	0.0219	CbGpPWpGaD
Zaleplon—Psoriasis—Varenicline—nicotine dependence	0.00877	0.0148	CcSEcCtD
Zaleplon—GABRG2—Ligand-gated ion channel transport—GABRA4—nicotine dependence	0.00874	0.0215	CbGpPWpGaD
Zaleplon—Parosmia—Varenicline—nicotine dependence	0.0085	0.0143	CcSEcCtD
Zaleplon—CYP3A7—Xenobiotics—CYP2A7—nicotine dependence	0.00813	0.02	CbGpPWpGaD
Zaleplon—Intestinal obstruction—Varenicline—nicotine dependence	0.00809	0.0136	CcSEcCtD
Zaleplon—Delusion—Varenicline—nicotine dependence	0.00779	0.0131	CcSEcCtD
Zaleplon—Nystagmus—Varenicline—nicotine dependence	0.00772	0.013	CcSEcCtD
Zaleplon—GABRA1—Ligand-gated ion channel transport—GABRA4—nicotine dependence	0.00764	0.0188	CbGpPWpGaD
Zaleplon—Menorrhagia—Varenicline—nicotine dependence	0.00745	0.0125	CcSEcCtD
Zaleplon—Scotoma—Varenicline—nicotine dependence	0.00726	0.0122	CcSEcCtD
Zaleplon—Gingivitis—Varenicline—nicotine dependence	0.00703	0.0118	CcSEcCtD
Zaleplon—Nephrolithiasis—Varenicline—nicotine dependence	0.00686	0.0115	CcSEcCtD
Zaleplon—Disturbance in attention—Varenicline—nicotine dependence	0.00637	0.0107	CcSEcCtD
Zaleplon—Aggression—Varenicline—nicotine dependence	0.00628	0.0106	CcSEcCtD
Zaleplon—Ventricular extrasystoles—Varenicline—nicotine dependence	0.00611	0.0103	CcSEcCtD
Zaleplon—Thinking abnormal—Varenicline—nicotine dependence	0.00602	0.0101	CcSEcCtD
Zaleplon—Lacrimation increased—Varenicline—nicotine dependence	0.00598	0.0101	CcSEcCtD
Zaleplon—CYP3A5—Xenobiotics—CYP2A7—nicotine dependence	0.00587	0.0145	CbGpPWpGaD
Zaleplon—Leukocytosis—Varenicline—nicotine dependence	0.00587	0.00987	CcSEcCtD
Zaleplon—Dysarthria—Varenicline—nicotine dependence	0.00583	0.00981	CcSEcCtD
Zaleplon—Coordination abnormal—Varenicline—nicotine dependence	0.00562	0.00945	CcSEcCtD
Zaleplon—Pulmonary embolism—Varenicline—nicotine dependence	0.00551	0.00928	CcSEcCtD
Zaleplon—Eructation—Varenicline—nicotine dependence	0.00542	0.00912	CcSEcCtD
Zaleplon—Salivary hypersecretion—Varenicline—nicotine dependence	0.00536	0.00901	CcSEcCtD
Zaleplon—Nightmare—Varenicline—nicotine dependence	0.00532	0.00896	CcSEcCtD
Zaleplon—Photophobia—Varenicline—nicotine dependence	0.00518	0.00871	CcSEcCtD
Zaleplon—Dry eye—Varenicline—nicotine dependence	0.00509	0.00857	CcSEcCtD
Zaleplon—GABRB2—GABA receptor activation—GABRA4—nicotine dependence	0.00507	0.0125	CbGpPWpGaD
Zaleplon—Oesophagitis—Varenicline—nicotine dependence	0.00504	0.00848	CcSEcCtD
Zaleplon—Mouth ulceration—Varenicline—nicotine dependence	0.00499	0.00839	CcSEcCtD
Zaleplon—Hypertonia—Varenicline—nicotine dependence	0.00483	0.00813	CcSEcCtD
Zaleplon—Mental disability—Varenicline—nicotine dependence	0.00479	0.00805	CcSEcCtD
Zaleplon—GABRA2—GABA receptor activation—GABRA4—nicotine dependence	0.00475	0.0117	CbGpPWpGaD
Zaleplon—Euphoric mood—Varenicline—nicotine dependence	0.00474	0.00797	CcSEcCtD
Zaleplon—GABRB3—GABA receptor activation—GABRA4—nicotine dependence	0.00472	0.0116	CbGpPWpGaD
Zaleplon—Lymphadenopathy—Varenicline—nicotine dependence	0.00469	0.00789	CcSEcCtD
Zaleplon—GABRG2—GABA receptor activation—GABRA4—nicotine dependence	0.00464	0.0114	CbGpPWpGaD
Zaleplon—Diabetes mellitus—Varenicline—nicotine dependence	0.0046	0.00774	CcSEcCtD
Zaleplon—Deafness—Varenicline—nicotine dependence	0.00447	0.00753	CcSEcCtD
Zaleplon—Eczema—Varenicline—nicotine dependence	0.00445	0.0075	CcSEcCtD
Zaleplon—Eye pain—Varenicline—nicotine dependence	0.00443	0.00746	CcSEcCtD
Zaleplon—Libido decreased—Varenicline—nicotine dependence	0.00432	0.00726	CcSEcCtD
Zaleplon—Increased appetite—Varenicline—nicotine dependence	0.00426	0.00717	CcSEcCtD
Zaleplon—Amnesia—Varenicline—nicotine dependence	0.00426	0.00717	CcSEcCtD
Zaleplon—Thirst—Varenicline—nicotine dependence	0.00421	0.00708	CcSEcCtD
Zaleplon—Arthritis—Varenicline—nicotine dependence	0.00412	0.00693	CcSEcCtD
Zaleplon—Hypoglycaemia—Varenicline—nicotine dependence	0.0041	0.0069	CcSEcCtD
Zaleplon—GABRA1—GABA receptor activation—GABRA4—nicotine dependence	0.00405	0.00999	CbGpPWpGaD
Zaleplon—Osteoarthritis—Varenicline—nicotine dependence	0.004	0.00674	CcSEcCtD
Zaleplon—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.00397	0.00668	CcSEcCtD
Zaleplon—Affect lability—Varenicline—nicotine dependence	0.00394	0.00663	CcSEcCtD
Zaleplon—Migraine—Varenicline—nicotine dependence	0.00394	0.00663	CcSEcCtD
Zaleplon—Psychotic disorder—Varenicline—nicotine dependence	0.00391	0.00658	CcSEcCtD
Zaleplon—Irritability—Varenicline—nicotine dependence	0.00382	0.00643	CcSEcCtD
Zaleplon—Urinary retention—Varenicline—nicotine dependence	0.00381	0.0064	CcSEcCtD
Zaleplon—Mood swings—Varenicline—nicotine dependence	0.00379	0.00638	CcSEcCtD
Zaleplon—Liver function test abnormal—Varenicline—nicotine dependence	0.0037	0.00622	CcSEcCtD
Zaleplon—Dry skin—Varenicline—nicotine dependence	0.00367	0.00617	CcSEcCtD
Zaleplon—Breast disorder—Varenicline—nicotine dependence	0.00362	0.00609	CcSEcCtD
Zaleplon—Gastritis—Varenicline—nicotine dependence	0.00354	0.00596	CcSEcCtD
Zaleplon—Dysphagia—Varenicline—nicotine dependence	0.00346	0.00582	CcSEcCtD
Zaleplon—Asthma—Varenicline—nicotine dependence	0.00346	0.00582	CcSEcCtD
Zaleplon—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB3—nicotine dependence	0.0034	0.00838	CbGpPWpGaD
Zaleplon—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00337	0.00832	CbGpPWpGaD
Zaleplon—Angina pectoris—Varenicline—nicotine dependence	0.00337	0.00567	CcSEcCtD
Zaleplon—CYP3A7—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00333	0.00821	CbGpPWpGaD
Zaleplon—Bronchitis—Varenicline—nicotine dependence	0.00333	0.0056	CcSEcCtD
Zaleplon—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA6—nicotine dependence	0.00322	0.00795	CbGpPWpGaD
Zaleplon—Pollakiuria—Varenicline—nicotine dependence	0.0032	0.00538	CcSEcCtD
Zaleplon—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB3—nicotine dependence	0.00319	0.00786	CbGpPWpGaD
Zaleplon—Erectile dysfunction—Varenicline—nicotine dependence	0.00319	0.00536	CcSEcCtD
Zaleplon—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB3—nicotine dependence	0.00317	0.00781	CbGpPWpGaD
Zaleplon—Photosensitivity reaction—Varenicline—nicotine dependence	0.00316	0.00531	CcSEcCtD
Zaleplon—Weight increased—Varenicline—nicotine dependence	0.00315	0.0053	CcSEcCtD
Zaleplon—Hyperglycaemia—Varenicline—nicotine dependence	0.00312	0.00525	CcSEcCtD
Zaleplon—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB3—nicotine dependence	0.00311	0.00767	CbGpPWpGaD
Zaleplon—Depression—Varenicline—nicotine dependence	0.00308	0.00518	CcSEcCtD
Zaleplon—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA6—nicotine dependence	0.00302	0.00745	CbGpPWpGaD
Zaleplon—Stomatitis—Varenicline—nicotine dependence	0.00301	0.00506	CcSEcCtD
Zaleplon—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA6—nicotine dependence	0.003	0.0074	CbGpPWpGaD
Zaleplon—Conjunctivitis—Varenicline—nicotine dependence	0.003	0.00505	CcSEcCtD
Zaleplon—GABRB2—Orphan transporters—GABRA4—nicotine dependence	0.00296	0.00729	CbGpPWpGaD
Zaleplon—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA6—nicotine dependence	0.00295	0.00727	CbGpPWpGaD
Zaleplon—Hepatobiliary disease—Varenicline—nicotine dependence	0.00292	0.00491	CcSEcCtD
Zaleplon—Epistaxis—Varenicline—nicotine dependence	0.00291	0.0049	CcSEcCtD
Zaleplon—GABRA2—Orphan transporters—GABRA4—nicotine dependence	0.00277	0.00683	CbGpPWpGaD
Zaleplon—Hallucination—Varenicline—nicotine dependence	0.00276	0.00464	CcSEcCtD
Zaleplon—Hypoaesthesia—Varenicline—nicotine dependence	0.00276	0.00464	CcSEcCtD
Zaleplon—GABRB3—Orphan transporters—GABRA4—nicotine dependence	0.00275	0.00679	CbGpPWpGaD
Zaleplon—CYP3A7—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00274	0.00674	CbGpPWpGaD
Zaleplon—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00273	0.00673	CbGpPWpGaD
Zaleplon—Oedema peripheral—Varenicline—nicotine dependence	0.00273	0.00459	CcSEcCtD
Zaleplon—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB3—nicotine dependence	0.00272	0.0067	CbGpPWpGaD
Zaleplon—GABRG2—Orphan transporters—GABRA4—nicotine dependence	0.0027	0.00666	CbGpPWpGaD
Zaleplon—Visual impairment—Varenicline—nicotine dependence	0.00267	0.00449	CcSEcCtD
Zaleplon—Eye disorder—Varenicline—nicotine dependence	0.00259	0.00435	CcSEcCtD
Zaleplon—Tinnitus—Varenicline—nicotine dependence	0.00258	0.00434	CcSEcCtD
Zaleplon—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA6—nicotine dependence	0.00258	0.00635	CbGpPWpGaD
Zaleplon—GABRB2—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00256	0.0063	CbGpPWpGaD
Zaleplon—Immune system disorder—Varenicline—nicotine dependence	0.0025	0.00421	CcSEcCtD
Zaleplon—Chills—Varenicline—nicotine dependence	0.00248	0.00418	CcSEcCtD
Zaleplon—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00244	0.00601	CbGpPWpGaD
Zaleplon—Mental disorder—Varenicline—nicotine dependence	0.00243	0.00408	CcSEcCtD
Zaleplon—GABRB2—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00242	0.00597	CbGpPWpGaD
Zaleplon—Malnutrition—Varenicline—nicotine dependence	0.00241	0.00406	CcSEcCtD
Zaleplon—CYP3A5—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00241	0.00593	CbGpPWpGaD
Zaleplon—GABRA2—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.0024	0.00591	CbGpPWpGaD
Zaleplon—GABRB3—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00238	0.00587	CbGpPWpGaD
Zaleplon—Flatulence—Varenicline—nicotine dependence	0.00238	0.004	CcSEcCtD
Zaleplon—GABRA1—Orphan transporters—GABRA4—nicotine dependence	0.00236	0.00583	CbGpPWpGaD
Zaleplon—Dysgeusia—Varenicline—nicotine dependence	0.00236	0.00397	CcSEcCtD
Zaleplon—GABRG2—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00234	0.00576	CbGpPWpGaD
Zaleplon—Back pain—Varenicline—nicotine dependence	0.00233	0.00392	CcSEcCtD
Zaleplon—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA4—nicotine dependence	0.00233	0.00574	CbGpPWpGaD
Zaleplon—GABRA2—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00227	0.0056	CbGpPWpGaD
Zaleplon—Tremor—Varenicline—nicotine dependence	0.00226	0.0038	CcSEcCtD
Zaleplon—GABRB3—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00226	0.00556	CbGpPWpGaD
Zaleplon—Ill-defined disorder—Varenicline—nicotine dependence	0.00224	0.00376	CcSEcCtD
Zaleplon—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—nicotine dependence	0.00223	0.00551	CbGpPWpGaD
Zaleplon—Anaemia—Varenicline—nicotine dependence	0.00223	0.00375	CcSEcCtD
Zaleplon—GABRG2—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00222	0.00546	CbGpPWpGaD
Zaleplon—Agitation—Varenicline—nicotine dependence	0.00222	0.00373	CcSEcCtD
Zaleplon—Angioedema—Varenicline—nicotine dependence	0.0022	0.00371	CcSEcCtD
Zaleplon—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA4—nicotine dependence	0.00218	0.00539	CbGpPWpGaD
Zaleplon—Malaise—Varenicline—nicotine dependence	0.00217	0.00366	CcSEcCtD
Zaleplon—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA4—nicotine dependence	0.00217	0.00535	CbGpPWpGaD
Zaleplon—Vertigo—Varenicline—nicotine dependence	0.00217	0.00364	CcSEcCtD
Zaleplon—Syncope—Varenicline—nicotine dependence	0.00216	0.00364	CcSEcCtD
Zaleplon—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA4—nicotine dependence	0.00213	0.00525	CbGpPWpGaD
Zaleplon—Palpitations—Varenicline—nicotine dependence	0.00213	0.00358	CcSEcCtD
Zaleplon—Loss of consciousness—Varenicline—nicotine dependence	0.00212	0.00357	CcSEcCtD
Zaleplon—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—nicotine dependence	0.00209	0.00516	CbGpPWpGaD
Zaleplon—Hypertension—Varenicline—nicotine dependence	0.00208	0.0035	CcSEcCtD
Zaleplon—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—nicotine dependence	0.00208	0.00513	CbGpPWpGaD
Zaleplon—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—nicotine dependence	0.00208	0.00512	CbGpPWpGaD
Zaleplon—GABRB2—Ion channel transport—GABRA4—nicotine dependence	0.00207	0.00511	CbGpPWpGaD
Zaleplon—Chest pain—Varenicline—nicotine dependence	0.00205	0.00345	CcSEcCtD
Zaleplon—Arthralgia—Varenicline—nicotine dependence	0.00205	0.00345	CcSEcCtD
Zaleplon—Myalgia—Varenicline—nicotine dependence	0.00205	0.00345	CcSEcCtD
Zaleplon—Anxiety—Varenicline—nicotine dependence	0.00205	0.00344	CcSEcCtD
Zaleplon—GABRA1—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00204	0.00504	CbGpPWpGaD
Zaleplon—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—nicotine dependence	0.00204	0.00504	CbGpPWpGaD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00204	0.00343	CcSEcCtD
Zaleplon—Discomfort—Varenicline—nicotine dependence	0.00203	0.00341	CcSEcCtD
Zaleplon—Dry mouth—Varenicline—nicotine dependence	0.00201	0.00338	CcSEcCtD
Zaleplon—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00198	0.00487	CbGpPWpGaD
Zaleplon—Oedema—Varenicline—nicotine dependence	0.00197	0.00331	CcSEcCtD
Zaleplon—GABRB2—Neuronal System—CHRNB3—nicotine dependence	0.00196	0.00483	CbGpPWpGaD
Zaleplon—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—nicotine dependence	0.00195	0.0048	CbGpPWpGaD
Zaleplon—GABRA2—Ion channel transport—GABRA4—nicotine dependence	0.00194	0.00479	CbGpPWpGaD
Zaleplon—GABRA1—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00194	0.00478	CbGpPWpGaD
Zaleplon—Shock—Varenicline—nicotine dependence	0.00194	0.00326	CcSEcCtD
Zaleplon—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—nicotine dependence	0.00193	0.00477	CbGpPWpGaD
Zaleplon—GABRB3—Ion channel transport—GABRA4—nicotine dependence	0.00193	0.00476	CbGpPWpGaD
Zaleplon—Nervous system disorder—Varenicline—nicotine dependence	0.00193	0.00325	CcSEcCtD
Zaleplon—Tachycardia—Varenicline—nicotine dependence	0.00192	0.00323	CcSEcCtD
Zaleplon—Skin disorder—Varenicline—nicotine dependence	0.00191	0.00322	CcSEcCtD
Zaleplon—Hyperhidrosis—Varenicline—nicotine dependence	0.0019	0.0032	CcSEcCtD
Zaleplon—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—nicotine dependence	0.0019	0.00468	CbGpPWpGaD
Zaleplon—GABRG2—Ion channel transport—GABRA4—nicotine dependence	0.0019	0.00468	CbGpPWpGaD
Zaleplon—Anorexia—Varenicline—nicotine dependence	0.00188	0.00316	CcSEcCtD
Zaleplon—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA4—nicotine dependence	0.00186	0.00459	CbGpPWpGaD
Zaleplon—GABRB2—Neuronal System—CHRNA6—nicotine dependence	0.00186	0.00458	CbGpPWpGaD
Zaleplon—Hypotension—Varenicline—nicotine dependence	0.00184	0.00309	CcSEcCtD
Zaleplon—GABRA2—Neuronal System—CHRNB3—nicotine dependence	0.00184	0.00453	CbGpPWpGaD
Zaleplon—GABRB3—Neuronal System—CHRNB3—nicotine dependence	0.00182	0.0045	CbGpPWpGaD
Zaleplon—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00179	0.00302	CcSEcCtD
Zaleplon—GABRG2—Neuronal System—CHRNB3—nicotine dependence	0.00179	0.00442	CbGpPWpGaD
Zaleplon—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—nicotine dependence	0.00179	0.0044	CbGpPWpGaD
Zaleplon—Insomnia—Varenicline—nicotine dependence	0.00178	0.00299	CcSEcCtD
Zaleplon—Dyspnoea—Varenicline—nicotine dependence	0.00175	0.00295	CcSEcCtD
Zaleplon—GABRB2—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00175	0.00432	CbGpPWpGaD
Zaleplon—Somnolence—Varenicline—nicotine dependence	0.00175	0.00294	CcSEcCtD
Zaleplon—GABRA2—Neuronal System—CHRNA6—nicotine dependence	0.00174	0.00429	CbGpPWpGaD
Zaleplon—Dyspepsia—Varenicline—nicotine dependence	0.00173	0.00291	CcSEcCtD
Zaleplon—GABRB3—Neuronal System—CHRNA6—nicotine dependence	0.00173	0.00426	CbGpPWpGaD
Zaleplon—Decreased appetite—Varenicline—nicotine dependence	0.00171	0.00288	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Varenicline—nicotine dependence	0.0017	0.00286	CcSEcCtD
Zaleplon—GABRG2—Neuronal System—CHRNA6—nicotine dependence	0.0017	0.00419	CbGpPWpGaD
Zaleplon—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.00169	0.00417	CbGpPWpGaD
Zaleplon—Pain—Varenicline—nicotine dependence	0.00168	0.00283	CcSEcCtD
Zaleplon—Constipation—Varenicline—nicotine dependence	0.00168	0.00283	CcSEcCtD
Zaleplon—GABRB2—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00168	0.00414	CbGpPWpGaD
Zaleplon—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—nicotine dependence	0.00166	0.00409	CbGpPWpGaD
Zaleplon—GABRA1—Ion channel transport—GABRA4—nicotine dependence	0.00166	0.00409	CbGpPWpGaD
Zaleplon—GABRA2—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00164	0.00405	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00164	0.00404	CbGpPWpGaD
Zaleplon—GABRB3—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00163	0.00402	CbGpPWpGaD
Zaleplon—Feeling abnormal—Varenicline—nicotine dependence	0.00162	0.00273	CcSEcCtD
Zaleplon—Gastrointestinal pain—Varenicline—nicotine dependence	0.00161	0.00271	CcSEcCtD
Zaleplon—GABRG2—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.0016	0.00395	CbGpPWpGaD
Zaleplon—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.00159	0.00391	CbGpPWpGaD
Zaleplon—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.00158	0.00389	CbGpPWpGaD
Zaleplon—GABRA2—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00157	0.00388	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—CHRNB3—nicotine dependence	0.00157	0.00386	CbGpPWpGaD
Zaleplon—GABRB3—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00156	0.00386	CbGpPWpGaD
Zaleplon—Urticaria—Varenicline—nicotine dependence	0.00156	0.00263	CcSEcCtD
Zaleplon—GABRB2—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00156	0.00385	CbGpPWpGaD
Zaleplon—Abdominal pain—Varenicline—nicotine dependence	0.00156	0.00262	CcSEcCtD
Zaleplon—Body temperature increased—Varenicline—nicotine dependence	0.00156	0.00262	CcSEcCtD
Zaleplon—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.00155	0.00382	CbGpPWpGaD
Zaleplon—CYP3A7—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00154	0.0038	CbGpPWpGaD
Zaleplon—GABRG2—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00154	0.00379	CbGpPWpGaD
Zaleplon—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.00149	0.00367	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—CHRNA6—nicotine dependence	0.00148	0.00366	CbGpPWpGaD
Zaleplon—GABRA2—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00146	0.00361	CbGpPWpGaD
Zaleplon—GABRB3—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00145	0.00359	CbGpPWpGaD
Zaleplon—CYP3A7—Biological oxidations—CYP2A7—nicotine dependence	0.00145	0.00358	CbGpPWpGaD
Zaleplon—CYP3A7—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00143	0.00353	CbGpPWpGaD
Zaleplon—GABRG2—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00143	0.00352	CbGpPWpGaD
Zaleplon—Asthenia—Varenicline—nicotine dependence	0.00141	0.00238	CcSEcCtD
Zaleplon—GABRA1—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.0014	0.00345	CbGpPWpGaD
Zaleplon—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.0014	0.00345	CbGpPWpGaD
Zaleplon—Pruritus—Varenicline—nicotine dependence	0.00139	0.00234	CcSEcCtD
Zaleplon—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.00139	0.00342	CbGpPWpGaD
Zaleplon—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.00136	0.00336	CbGpPWpGaD
Zaleplon—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.00135	0.00334	CbGpPWpGaD
Zaleplon—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.00135	0.00334	CbGpPWpGaD
Zaleplon—GABRA1—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00134	0.00331	CbGpPWpGaD
Zaleplon—GABRB2—Neuronal System—GABRA4—nicotine dependence	0.00134	0.00331	CbGpPWpGaD
Zaleplon—Dizziness—Varenicline—nicotine dependence	0.0013	0.00219	CcSEcCtD
Zaleplon—GABRB2—Neuronal System—CHRNB4—nicotine dependence	0.00129	0.00317	CbGpPWpGaD
Zaleplon—GABRB2—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00127	0.00314	CbGpPWpGaD
Zaleplon—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.00127	0.00313	CbGpPWpGaD
Zaleplon—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.00126	0.00311	CbGpPWpGaD
Zaleplon—GABRA2—Neuronal System—GABRA4—nicotine dependence	0.00126	0.0031	CbGpPWpGaD
Zaleplon—GABRB3—Neuronal System—GABRA4—nicotine dependence	0.00125	0.00308	CbGpPWpGaD
Zaleplon—GABRA1—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00125	0.00308	CbGpPWpGaD
Zaleplon—Rash—Varenicline—nicotine dependence	0.00124	0.00209	CcSEcCtD
Zaleplon—Dermatitis—Varenicline—nicotine dependence	0.00124	0.00209	CcSEcCtD
Zaleplon—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.00124	0.00305	CbGpPWpGaD
Zaleplon—Headache—Varenicline—nicotine dependence	0.00123	0.00207	CcSEcCtD
Zaleplon—GABRG2—Neuronal System—GABRA4—nicotine dependence	0.00123	0.00303	CbGpPWpGaD
Zaleplon—GABRA2—Neuronal System—CHRNB4—nicotine dependence	0.00121	0.00297	CbGpPWpGaD
Zaleplon—GABRB3—Neuronal System—CHRNB4—nicotine dependence	0.0012	0.00295	CbGpPWpGaD
Zaleplon—GABRB2—Neuronal System—CHRNA5—nicotine dependence	0.0012	0.00295	CbGpPWpGaD
Zaleplon—GABRA2—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00119	0.00294	CbGpPWpGaD
Zaleplon—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.00119	0.00294	CbGpPWpGaD
Zaleplon—GABRB3—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00119	0.00292	CbGpPWpGaD
Zaleplon—GABRG2—Neuronal System—CHRNB4—nicotine dependence	0.00118	0.0029	CbGpPWpGaD
Zaleplon—Nausea—Varenicline—nicotine dependence	0.00117	0.00197	CcSEcCtD
Zaleplon—GABRG2—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00116	0.00287	CbGpPWpGaD
Zaleplon—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00113	0.0028	CbGpPWpGaD
Zaleplon—GABRA2—Neuronal System—CHRNA5—nicotine dependence	0.00112	0.00276	CbGpPWpGaD
Zaleplon—GABRB2—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00112	0.00276	CbGpPWpGaD
Zaleplon—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00112	0.00276	CbGpPWpGaD
Zaleplon—GABRB3—Neuronal System—CHRNA5—nicotine dependence	0.00111	0.00275	CbGpPWpGaD
Zaleplon—CYP3A5—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00111	0.00275	CbGpPWpGaD
Zaleplon—GABRG2—Neuronal System—CHRNA5—nicotine dependence	0.00109	0.0027	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00109	0.00269	CbGpPWpGaD
Zaleplon—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.00108	0.00267	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—GABRA4—nicotine dependence	0.00107	0.00265	CbGpPWpGaD
Zaleplon—GABRA2—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00105	0.00259	CbGpPWpGaD
Zaleplon—CYP3A5—Biological oxidations—CYP2A7—nicotine dependence	0.00105	0.00259	CbGpPWpGaD
Zaleplon—GABRB3—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00104	0.00257	CbGpPWpGaD
Zaleplon—CYP3A5—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00104	0.00255	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—CHRNB4—nicotine dependence	0.00103	0.00254	CbGpPWpGaD
Zaleplon—GABRG2—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00103	0.00253	CbGpPWpGaD
Zaleplon—GABRA1—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00102	0.00251	CbGpPWpGaD
Zaleplon—GABRB2—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00102	0.00251	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.000992	0.00245	CbGpPWpGaD
Zaleplon—GABRB2—Neuronal System—CHRNA3—nicotine dependence	0.000975	0.0024	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—CHRNA5—nicotine dependence	0.000957	0.00236	CbGpPWpGaD
Zaleplon—GABRA2—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000954	0.00235	CbGpPWpGaD
Zaleplon—GABRB3—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000948	0.00234	CbGpPWpGaD
Zaleplon—GABRG2—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000931	0.00229	CbGpPWpGaD
Zaleplon—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000919	0.00227	CbGpPWpGaD
Zaleplon—GABRA2—Neuronal System—CHRNA3—nicotine dependence	0.000914	0.00225	CbGpPWpGaD
Zaleplon—GABRB3—Neuronal System—CHRNA3—nicotine dependence	0.000908	0.00224	CbGpPWpGaD
Zaleplon—GABRA1—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000896	0.00221	CbGpPWpGaD
Zaleplon—GABRG2—Neuronal System—CHRNA3—nicotine dependence	0.000892	0.0022	CbGpPWpGaD
Zaleplon—GABRB2—Neuronal System—CHRNB2—nicotine dependence	0.000859	0.00212	CbGpPWpGaD
Zaleplon—GABRA1—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000814	0.00201	CbGpPWpGaD
Zaleplon—GABRA2—Neuronal System—CHRNB2—nicotine dependence	0.000805	0.00198	CbGpPWpGaD
Zaleplon—GABRB3—Neuronal System—CHRNB2—nicotine dependence	0.0008	0.00197	CbGpPWpGaD
Zaleplon—GABRG2—Neuronal System—CHRNB2—nicotine dependence	0.000785	0.00194	CbGpPWpGaD
Zaleplon—GABRB2—Neuronal System—CHRNA4—nicotine dependence	0.00078	0.00192	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—CHRNA3—nicotine dependence	0.00078	0.00192	CbGpPWpGaD
Zaleplon—GABRA2—Neuronal System—CHRNA4—nicotine dependence	0.000731	0.0018	CbGpPWpGaD
Zaleplon—GABRB3—Neuronal System—CHRNA4—nicotine dependence	0.000726	0.00179	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000722	0.00178	CbGpPWpGaD
Zaleplon—GABRG2—Neuronal System—CHRNA4—nicotine dependence	0.000713	0.00176	CbGpPWpGaD
Zaleplon—AOX1—Disease—AKR1B10—nicotine dependence	0.000711	0.00175	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—CHRNB2—nicotine dependence	0.000686	0.00169	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000677	0.00167	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000672	0.00166	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00066	0.00163	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—CHRNA4—nicotine dependence	0.000623	0.00154	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000577	0.00142	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CYP2A7—nicotine dependence	0.000553	0.00136	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000518	0.00128	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000488	0.0012	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000482	0.00119	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP2A7—nicotine dependence	0.000248	0.000613	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP2A7—nicotine dependence	0.00018	0.000443	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP2A7—nicotine dependence	8.35e-05	0.000206	CbGpPWpGaD
